Mantle Cell Lymphoma Video Channel
Explore the latest insights and summaries from experts in Mantle Cell Lymphoma.
Therapeutic Agents
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Management of MCL
FEATURING
Andre Goy
- 132 views
- March 27, 2024
- 3
University of Miami Sylvester Comprehensive Cancer Center
Using BTKis in MCL Today
FEATURING
Alvaro Alencar
- 66 views
- May 7, 2024
University of Miami Sylvester Comprehensive Cancer Center
Evaluating Zanubrutinib + Tafasitamab in MCL
FEATURING
Alvaro Alencar
- 26 views
- May 7, 2024
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: SYMPATICO Study - Ibrutinib + Venetoclax in MCL With TP53 Mutations
FEATURING
Wojciech Jurczak
- 39 views
- June 30, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Benefit of R Maintenance After 1L BR in MCL"
FEATURING
Yucai Wang
- 70 views
- July 11, 2024
- 1
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Sonrotoclax and Zanubrutinib Combination Therapy for R/R MCL
FEATURING
Constantine Tam
- 24 views
- July 18, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in the Treatment of MCL
FEATURING
Georg Hess
- 252 views
- September 27, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Acalabrutinib, Venetoclax, and Obinutuzumab in Patients With MCL - MAVO Phase 1/2 Study
FEATURING
Austin Kim
- 16 views
- December 13, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MCL - Highlights & Key Takeaways"
FEATURING
Victor Yazbeck
- 173 views
- January 24, 2024
- 1